Log in
Enquire now
‌

US Patent 10358421 Piperidine derivatives as HDAC1/2 inhibitors

Patent 10358421 was granted and assigned to Regenacy Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Regenacy Pharmaceuticals
Regenacy Pharmaceuticals
Current Assignee
Regenacy Pharmaceuticals
Regenacy Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
103584210
Patent Inventor Names
John H. van Duzer0
Ralph Mazitschek0
Date of Patent
July 23, 2019
0
Patent Application Number
157009980
Date Filed
September 11, 2017
0
Patent Citations Received
‌
US Patent 11702389 Piperidine derivatives as HDAC1/2 inhibitors
0
Patent Primary Examiner
‌
Timothy P Thomas
0
Patent abstract

Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC1 and/or HDAC2 activity.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10358421 Piperidine derivatives as HDAC1/2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.